From: A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism
Before progesterone | On progesterone | |
---|---|---|
Height (cm) | 152 ± 2.2 | 153.3 ± 2.2a |
Weight (kg) | 50.3 ± 7.7 | 53.1 ± 7.2a |
Estradiol (pg/mL) | 26 ± 10.4 | 11 ± 3.7 |
Estrone Sulfate (ng/dL) | 204 ± 75 | 217 ± 115 |
HS-CRP (mg/L) | 1.82 ± 1.42 | 3.83 ± 1.94 |
Fibrinogen Activity (mg/dL) | 267 ± 32.2 | 310 ± 30.5 |
Antithrombin Activity (%) | 109 ± 3.1 | 117 ± 7.2 |
Glucose (mg/dL) | 81 ± 2.2 | 80 ± 1.6 |
ALT (U/L) | 21 ± 5.5 | 26 ± 7.8 |
Triglycerides (mg/dL) | 122 ± 23.6 | 111 ± 20 |
LDL (mg/dL) | 84 ± 6.8 | 84 ± 5.7 |
IGF-1 (ng/mL) | 416 ± 55 | 314 ± 56 |
Menses | 50 % |